CRC 1450 - A07: Image-guided tumour therapies with CAR T cells co-engineered for local depletion of immunosuppressive macrophages

Basic data for this project

Type of projectSubproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster01/01/2025 - 31/12/2028 | 1st Funding period

Description

We aim to enable effective T cell targeting of solid cancers by co-engineering T cells with tumour-antigen specific CARs and for local release of an antagonist that selectively depletes immunosuppressive myeloid cell populations in tumour tissues. Our multimodal cellular targeting and imaging strategy will include in vivo tracking of the inflammatory tumour microenvironment, the fate of the CAR T cells and released antagonist along with local tumour growth and dissemination. The insights from this project will inform clinical translation of this novel strategy.

KeywordsMakrophagen; Bildgebung; T-Zellen
Website of the projecthttps://www.uni-muenster.de/CRC-inSight/research/area-A/A07.php
DFG-Gepris-IDhttps://gepris.dfg.de/gepris/projekt/549338034
Funding identifierSFB 1450/2, A07
Funder / funding scheme
  • DFG - Collaborative Research Centre (SFB)

Project management at the University of Münster

Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)

Applicants from the University of Münster

Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)